The clinical relevance of endotoxin in human sepsis: A critical analysis

Journal of Endotoxin Research

Volumn 8, Issue 6, 2002, Pages 473-476

  Opal, Steven M ^a  

^a MEMORIAL HOSPITAL OF RHODE ISLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; ENDOTOXIN; LIPOPOLYSACCHARIDE; LIPOPOLYSACCHARIDE BINDING PROTEIN; TOLL LIKE RECEPTOR 4;

BLOOD SAMPLING; DNA POLYMORPHISM; ENDOTOXEMIA; HUMAN; IMMUNE RESPONSE; MORBIDITY; MORTALITY; OUTCOMES RESEARCH; PATHOPHYSIOLOGY; PROGNOSIS; REVIEW; RISK ASSESSMENT; RISK FACTOR; SEPSIS;

HUMANS; KINETICS; LIPOPOLYSACCHARIDES; MORBIDITY; PROGNOSIS; SEPSIS;

EID: 0036954167     PISSN: 09680519     EISSN: None     Source Type: Journal    
DOI: 10.1179/096805102125001109     Document Type: Review

References (37)

1. Westphal O, Westphal U, Sommer T. The history of pyrogen research. In: Schlessinger D. (ed) Microbiol 1977. Washington, DC: American Society of Microbiology 1997; 221-238.
2. Opal SM, Yu Jr RL. Antiendotoxin strategies for the prevention and treatment of septic shock new approaches and future directions. Drugs 1998; 55: 497-508.
3. DaSilva AMT, Kaulbach HC, Chuidian FS, Lambert DR, Suffredini AF, Danner RL. Shock and multiple organ dysfunction after self administration of Salmonella endotoxin. N Engl J Med 1993; 328: 1457-1460.
4. Means TK, Golenbock DT, Fenton MJ. The biology of Toll-like receptors. Cytokine Growth Factor Rev 2000; 11: 219-232.
5. Derkx B, Wittes J, McCloskey R, and the European Pediatric Meningococcal Septic Shock Trial Study Group. Randomized, placebo-controlled trial of HA-1A, a human monoclonal antibody to endotoxin, in children with meningococcal septic shock. Clin Infect Dis 1999; 28: 770-777.
6. Aliprintis AO, Yang RB, Mark MR et al. Cell activation and apoptosis by bacterial lipoproteins through Toll-like receptor-2. Science 1999; 285: 736-738.
7. van Deventer SJM, Buller HR, ten Cate JW, Sturk A, Paw W. Endotoxemia as an early predictor of septicaemia in febrile patients. Lancet 1988; 1: 605-608.
8. Bennett-Guerrero E, Ayuso L, Hamilton-Davies H et al. Relationship of preoperative antiendotoxin core antibodies and adverse outcomes following cardiac surgery. JAMA 1997; 277: 646-650.
9. Langevelde PV, Joop K, Loon JV et al. Endotoxin, cytokines, and procalcitonin in febrile patients admitted to the hospital: identification of subjects at high risk of mortality. Clin Infect Dis 2000; 31: 1343-1348.
10. Rauchaus M, Coats AJS, Anker SD. The endotoxin-lipoprotein hypothesis. Lancet 2000; 356: 930-933.
11. 21) as adjunctive treatment for children with severe meningococcal sepsis: a randomised trial. Lancet 2000; 356: 961-967.
12. Warren HS, Amato SF, Fitting C, Black KM, Loiselle PM, Pasternack MS. Assessment of ability of murine and human antilipid A monoclonal antibodies to bind and neutralize lipopolysaccharide. J Exp Med 1993; 177: 89-97.
13. Novitsky TJ. Limulus amebocyte lysate (LAL) detection of endotoxin in human blood. J Endotoxin Res 1994; 1: 253-263.
14. Levels JHM, Abraham PR, van den Ende A, van Deventer SJH. Distribution and kinetics of lipoprotein-bound endotoxin. Infect Immun 2001; 69: 2821-2828.
15. Gordon BR, Parker TS, Levine DM, Saal SD, Wang JC, Sloan BJ. Low lipid concentrations in critical illness: implications for preventing and treating endotoxemia. Crit Care Med 1996; 24: 584-589.
16. Lamping N, Dettmer R, Schroder NWJ et al. LPS-binding protein protects mice from septic shock caused by LSP or Gram-negative bacteria. J Clin Invest 1998; 101: 2065-2071.
17. Gibot S, Cariou A, Drouet L, Rossignol M, Ripoll L. Association between a genomic polymorphism with the CD 14 locus and septic shock susceptibility and mortality rate. Crit Care Med 2002; 30: 969-973.
18. La Van TD, Bloom JW, Bailey TJ et al. A common single nucleotide polymorphism in the CD14 promoter decreases the affinity of Sp protein binding and enhances transcriptional activity. J Immunol 2001; 167: 5838-5844.
19. Lorenz E, Mira JP, Frees KL, Schwartz DA. Relevance of mutations in the TLR4 receptor in patients with Gram-negative septic shock. Arch Intern Med 2002; 162: 1028-1031.
20. Nomura F, Akashi S, Sakao Y et al. Endotoxin tolerance in mouse peritoneal macrophages correlates with down-regulation of surface Toll-like receptor 4 expression. J Immunol 2000; 164: 3476-3479,
21. Varma TK, Toliver-Kinsky TE, Lin CY, Koutrouvelis AP, Nichols JE, Sherwood ER. Cellular mechanisms that cause suppressed gamma interferon secretion in endotoxin-tolerant mice. Infect Immun 2001; 69: 5249-5263.
22. Cohen J. TREM-1 in sepsis. Lancet 2001; 358: 776-778.
23. Gao JJ, Xue Q, Papasian CJ, Morrison DC. Bacterial DNA and lipopolysaccharide induce synergistic production of TNF-aaa through a post-transcriptional mechanism. J Immunol 2001; 166: 6855-6860.
24. Danner RL, Elin RJ, Hosseini JM. Wesley RA, Reilly JM, Parillo JE. Endotoxemia in human septic shock. Chest 1991; 99: 169-175.
25. Roger T, David J, Glauser W, Calandra T. MIF regulates innate immune responses through modulation of Toll-like receptor 4. Nature 2002; 414: 920-924.
26. Echtenacher B, Freudenberg MA, Jack RS, Mannel DN. Differences in innate defense mechanisms in endotoxemia and polymicrobial septic peritonitis. Infect Immun 2000 ; 69: 7271-7276.
27. Opal SM, Scannon PJ, Vincent JL et al. Relationship between plasma levels of lipopolysaccharide (LPS) and LPS-binding protein in patients with severe sepsis and septic shock. J Infect Dis 1999; 180: 1584-1589.
28. Hemmi H, Takeuchi O, Kawal T et al. A Toll-like receptor recognizes bacterial DNA. Nature 2000; 408: 740-744.
29. Hirschfeld M, Kirschning CJ, Schwandner R, Wesche H, Weis JH, Wooten RM. Inflammatory signaling by Borrelia burgdorferi lipoproteins is mediated by Toll-like receptor 2. J Immunol 1999: 163: 2382-2386.
30. Hayashi F, Smith KD, Ozinsky A et al. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 2001; 410: 1099-1103.
31. Huang Q, Liu D, Majewski P et al. The plasticity of dendritic cell responses to pathogens and their components. Science 2001; 294: 870-875.
32. Pridmore AC, Wyllie DH, Abdillahi F et al. A lipopolysaccharide-deficient mutant of Neisseria meningitidis elicits attenuated cytokine release by human macrophages and signals via Toll-like receptor (TLR) 2 but not via TLR4/MD2. J Infect Dis 2001; 183: 89-96.
33. Casey LC, Balk RA, Bone RC. Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Intern Med 1993; 119: 771-778.
34. Levin J, Poore TE, Young NS et al. Gram-negative sepsis: detection of endotoxemia with the Limulus test: with studies of associated changes in coagulation, serum lipids and complement. Ann Intern Med 1972; 76: 1-7.
35. Butler J, Levin J, Cu DG, Walker RI. Bubonic plague: detection of endotoxemia with the Limulus test. Ann Intern Med 1973; 79: 642-646.
36. Hurley JC. Endotoxemia: methods of detection and clinical correlates. Clin Microbiol Rev 1995; 8: 268-292.
37. Hurley JC. Concordance of endotoxemia with Gram-negative bacteremia: a meta-analysis using receiver operating characteristic curves. Arch Pathol Lab Med 2000; 124: 1157-1164.